These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37103073)
21. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189 [TBL] [Abstract][Full Text] [Related]
22. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes. Leggett CS; Doll MA; States JC; Hein DW Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180 [TBL] [Abstract][Full Text] [Related]
23. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse. Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913 [TBL] [Abstract][Full Text] [Related]
25. Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects. Vaziri SA; Hughes NC; Sampson H; Darlington G; Jewett MA; Grant DM Pharmacogenetics; 2001 Feb; 11(1):7-20. PubMed ID: 11207033 [TBL] [Abstract][Full Text] [Related]
26. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes. Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877 [TBL] [Abstract][Full Text] [Related]
28. Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis. Deloménie C; Goodfellow GH; Krishnamoorthy R; Grant DM; Dupret JM Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):207-15. PubMed ID: 9173883 [TBL] [Abstract][Full Text] [Related]
29. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162 [TBL] [Abstract][Full Text] [Related]
30. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A. Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736 [TBL] [Abstract][Full Text] [Related]
31. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512 [TBL] [Abstract][Full Text] [Related]
32. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549 [TBL] [Abstract][Full Text] [Related]
33. Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance. Minchin RF; Butcher NJ BMC Genomics; 2018 Jul; 19(1):513. PubMed ID: 29969986 [TBL] [Abstract][Full Text] [Related]
34. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Windmill KF; Gaedigk A; Hall PM; Samaratunga H; Grant DM; McManus ME Toxicol Sci; 2000 Mar; 54(1):19-29. PubMed ID: 10746928 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors. Rodrigues-Lima F; Dupret JM Curr Pharm Des; 2004; 10(20):2519-24. PubMed ID: 15320760 [TBL] [Abstract][Full Text] [Related]
37. Human Hein DW; Doll MA; Habil MR Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898 [TBL] [Abstract][Full Text] [Related]
38. Expression of arylamine N-acetyltransferase in human intestine. Hickman D; Pope J; Patil SD; Fakis G; Smelt V; Stanley LA; Payton M; Unadkat JD; Sim E Gut; 1998 Mar; 42(3):402-9. PubMed ID: 9577349 [TBL] [Abstract][Full Text] [Related]
39. Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat. Barker DF; Walraven JM; Ristagno EH; Doll MA; States JC; Hein DW Drug Metab Dispos; 2008 Dec; 36(12):2445-51. PubMed ID: 18799802 [TBL] [Abstract][Full Text] [Related]
40. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer. Majumder M; Ghosh S; Roy B Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]